Original articleCardiovascularMidterm Follow-Up of Tricuspid Valve Reconstruction Due to Active Infective Endocarditis
Section snippets
Material and Methods
Between October 1997 and July 2004, 22 consecutive patients with active tricuspid valve endocarditis underwent surgical treatment at our institution. In 1997 we started to aggressively use reconstructive techniques rather than valve replacement in all patients presenting with active infective tricuspid valve endocarditis. The aim of this retrospective study was to analyze our results after tricuspid valve reconstruction for active infective tricuspid endocarditis during at least a midterm
Results
There was no intraoperative death. Mean follow-up was 53 ± 18 months and was 81% complete (n = 17). The remaining 4 patients (3 patients in the reconstruction group and 1 patient in the replacement group) were not available for follow-up. However, in 3 of those patients recent discharge reports from other hospitals because of admissions for other medical reasons were obtained that did not indicate any recurrence of endocarditis or other cardiac problems, and none of these patients was quoted in
Comment
The incidence of tricuspid valve endocarditis has risen during the last three decades [14, 15] for several reasons: (1) The number of people addicted to intravenous drug abuse that predisposes to tricuspid valve endocarditis is growing [16]. (2) Advances in interventional electrophysiology have prolonged the survival of patients with heart block or malignant tachyarrhythmia, and there is a concomitant use of implantable devices as pacemakers and defibrillators [17, 18]. (3) There is an increase
References (36)
- et al.
Right-sided valvular infective endocarditisA clinicopathologic study of twelve necropsy patients
Am J Med
(1972) - et al.
Tricuspid valve endocarditis
Am Heart J
(1989) - et al.
Tricuspid valve endocarditis due to Staphylococcus aureus: correlation of two-dimensional echocardiography with clinical outcome
Chest
(1988) - et al.
Hemodynamic consequences of total removal of the tricuspid valve without prosthetic replacement
Am J Cardiol
(1975) - et al.
Infective endocarditis in patients with human immunodeficiency virus infection
J Infect
(2001) - et al.
Infective endocarditis in intravenous drug abusers and HIV-1 infected patients
Infect Dis Clin North Am
(2002) - et al.
Tricuspid valve endocarditis due to Staphylococcus aureus
Chest
(1988) - et al.
Infective endocarditis in heroin addicts
Am J Med
(1973) - et al.
Reparative approach for right-sided endocarditisOperative considerations and results of valvuloplasty
J Thorac Cardiovasc Surg
(1988) - et al.
Tricuspid valve replacementFifteen years of experience with mechanical prostheses and bioprostheses
J Thorac Cardiovasc Surg
(1995)
Long-term result of 1144 CarboMedics mechanical valve implantations
Ann Thorac Surg
Tricuspid valve replacement: postoperative and long-term results
J Thorac Cardiovasc Surg
Commissuroplasty: a method of valve repair for mitral and tricuspid endocarditis
Ann Thorac Surg
Tricuspid valve repair for tricuspid valve endocarditis after Fallot repair
Ann Thorac Surg
Valve repair in acute endocarditis
Ann Thorac Surg
Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963–72
Medicine
Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience
J Heart Valve Dis
Infective endocarditis in drug addicts: experiences with medical and surgical treatment
Circulation
Cited by (62)
Outcomes After Tricuspid Valve Operations in Patients With Drug-Use Infective Endocarditis
2022, American Journal of CardiologyCitation Excerpt :In addition to the increased risk of MACE discussed above, patients with DU-IE are at increased risk of recurrent endocarditis with rates as high as 50% because of relapse in DU, which poses a high risk for subsequent reoperation and increased short and long-term morbidity and mortality.23,24 Valve repair has more favorable outcomes than valve replacement as it avoids prosthetic implants, but it may not be suitable for all anatomies.25,26 Novel options for debulking valvular vegetations by way of percutaneous mechanical aspiration (PMA) have been explored using the Penumbra Indigo (Penumbra, Alameda, California) or AngioVac (Angiodynamics, Latham, New York) devices.27–29
Timing and indications for surgery
2022, Infective Endocarditis: A Multidisciplinary ApproachOptimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database
2021, Journal of Thoracic and Cardiovascular SurgeryInfective endocarditis in intravenous drug users
2020, Trends in Cardiovascular MedicineSurgical treatment of isolated tricuspid valve infective endocarditis: 25-year results from a multicenter registry
2019, International Journal of CardiologyCitation Excerpt :Recurrence episodes were few, but with an extremely ominous prognosis, underlining the relevance and complexity of the disease in such circumstances. The type of surgical procedure did not seem to affect postoperative results in this setting [4,5,12–15,17,18], suggesting that patient condition and predisposing factors may play a major role. In our analysis, age, mycotic TVIE, IVDU, redo operation for an infected prosthetic valve, and the presence of PMK leads, were all predictors of unfavorable outcome.
Surgical treatment of right-sided infective endocarditis
2019, Journal of Thoracic and Cardiovascular Surgery